0001536094-14-000001.txt : 20140815 0001536094-14-000001.hdr.sgml : 20140815 20140815153429 ACCESSION NUMBER: 0001536094-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140815 DATE AS OF CHANGE: 20140815 EFFECTIVENESS DATE: 20140815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oncothyreon Inc. CENTRAL INDEX KEY: 0001412067 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 260868560 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-223047 FILM NUMBER: 141046432 BUSINESS ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: (206) 801-2100 MAIL ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: Biomira CORP DATE OF NAME CHANGE: 20070911 D 1 primary_doc.xml X0707 D LIVE 0001412067 Oncothyreon Inc. 2601 FOURTH AVENUE SUITE 500 SEATTLE WA WASHINGTON 98121 (206) 801-2100 DELAWARE Biomira CORP Corporation true Robert L. Kirkman c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Executive Officer Director Julia Eastland c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Executive Officer Gary Christianson c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Executive Officer Diana Hausman c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Executive Officer Scott Peterson c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Executive Officer Jay Venkatesan c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Executive Officer Christopher Henney c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Director Richard Jackson c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Director Ted W. Love c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Director Daniel Spiegelman c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Director W. Vickery Stoughton c/o Oncothyreon Inc. 2601 Fourth Ave., Suite 500 Seattle WA WASHINGTON 98121 Director Biotechnology Decline to Disclose 06b false 2014-08-08 false true true 0 22861428 22861428 0 The securities were issued in connection with a merger, the consideration of which was the exchange of the target's securities for issuer securities. false 5 0 0 0 false Oncothyreon Inc. /s/JULIA EASTLAND JULIA EASTLAND CFO 2014-08-15